The results of the study showed that Piperine was able to inhibit the volume and weight of tumors in vivo in CRC model mice, increased the levels of LC3, LC3-II, ROS, and Beclin1, and decreased the levels of p-AKT and mTOR. The gene discussed is MAP1LC3A; the disease is colorectal carcinoma.